BRACCO DIAGNOSTICS INC. CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET

K123047 · Bracco Diagnostic, Inc. · FCX · Aug 6, 2013 · Gastroenterology, Urology

Device Facts

Record IDK123047
Device NameBRACCO DIAGNOSTICS INC. CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET
ApplicantBracco Diagnostic, Inc.
Product CodeFCX · Gastroenterology, Urology
Decision DateAug 6, 2013
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.1500
Device ClassClass 2

Indications for Use

The CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET is intended to connect a CO2 source (insufflator), and a sterile water source (water bottle), to an endoscope to supply CO2 during gastrointestinal endoscopic procedures.

Device Story

The CO2 Endoscopic Insufflator In Line Tubing Set (ILTS) is a disposable accessory used during gastrointestinal endoscopic procedures. It connects a CO2 insufflator and a sterile water bottle to compatible endoscopes (Olympus 140, 160, 180, and 190 series). The device facilitates the delivery of CO2 and sterile water to the endoscope. It is supplied sterile via Gamma radiation. The device is intended for use by clinicians in a clinical setting. By providing a sterile, disposable pathway for insufflation, it helps maintain the integrity of the endoscopic system and supports patient safety during procedures.

Clinical Evidence

Bench testing only. No clinical data provided. Performance testing included device compatibility, usability, environmental testing, delivery flow rate, delivery pressure, leakage, mechanical integrity, shipping/transportation, and labeling. Biocompatibility was verified per ISO 10993-1:2009. Sterilization and packaging were validated per ISO 11137-1/2 and ISO 11607-1/2.

Technological Characteristics

Disposable tubing set; Gamma radiation sterilized (SAL 10^-6); compliant with ISO 11137-1/2 and ISO 11607-1/2; biocompatible materials per ISO 10993-1:2009; connects to OEM endoscopes via external CO2 luer connector.

Indications for Use

Indicated for use in gastrointestinal endoscopic procedures to connect a CO2 insufflator and sterile water source to an endoscope for CO2 supply.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

In combination with the general controls of the FD&C Act, the integrated operating table-electromechanical surgical system is subject to the following special controls: 1. (1) Premarket clinical performance testing, or a combination of premarket clinical performance testing and postmarket surveillance (in accordance with special control (2)), must include the following: 1. (i) Objective performance measures (e.g., rate and number of conversions to other surgical modalities, rate of device related adverse events (including tissue injury, hematoma, and increased blood loss), and their severity, cause, and outcomes) must be reported with relevant descriptive comparator performance measures. 2. (ii) The data must demonstrate the performance of the device for providing accurate and precise control of attached surgical instruments in range of clinical conditions relevant to the device's intended use. 3. (iii) The test dataset must include data collected from a patient population representative of the intended patient population under anticipated conditions of use. 2. (2) Data obtained from postmarket surveillance must demonstrate, in consideration of the premarket data obtained in accordance with special control (1), that the device performs in accordance with special control (1), unless FDA determines, based on the totality of the premarket data, that data from postmarket surveillance is not required to demonstrate that the device performs as intended. Such postmarket surveillance must be conducted per a protocol determined appropriate by FDA to demonstrate that the device performs as intended (in consideration of the premarket data obtained in accordance with special control (1)), and must include initiation, enrollment, and reporting requirements to ensure timely periodic updates to FDA on post-market surveillance progress and outcomes. 3. (3) Animal performance testing must evaluate the extent of port site trauma due to repositioning of table during surgical procedures when utilizing robotic minimally invasive and laparoscopic approaches 4. (4) The device manufacturer must develop, and update as necessary, a device-specific use training program that ensures proper device setup/use/shutdown, accurate control of instruments to perform the intended surgical procedures, troubleshooting and handling during unexpected events or emergencies, and safe practices to mitigate use error. 5. (5) The device manufacturer may only distribute the device to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program. (6) Human factors assessment must demonstrate that the user can correctly use the device system across all intended use environments with the provided instructions and training materials, including patient access during normal operating conditions and emergency situations, and effects arising from the integrated nature of the operating table and robotic surgical arms. (7) Labeling must include: (i) A detailed summary of clinical performance testing conducted with the device, including study population, results, adverse events, and comparisons to any comparator groups identified; (ii) A statement in the labeling that the safety and effectiveness for the representative specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of the patient's underlying disease or condition, unless FDA determines that it can be removed or modified based on clinical performance data submitted to FDA; (iii) Identification of compatible devices; (iv) The list of surgical procedures for which the device has been determined to be safe with clinical justification; (v) Reprocessing instructions for reusable components; (vi) A shelf life for any sterile components; (vii) A description of the device-specific use training program; (viii) A statement that the device is only for distribution to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program; and (ix) A summary of any completed postmarket surveillance data collected as required by special control (2), including updated labeling to accurately reflect outcomes observed in postmarket surveillance. (8) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use and must include: (i) Device motion accuracy and repeatability; (ii) System testing; (iii) Instrument reliability; (iv) Crosstalk; (v) Table motion control; (vi) Thermal effects on tissue; (vii) User-device interface performance; (viii) Workspace access testing; and (ix) Performance testing with compatible devices. (9) Software verification, validation, and hazard analysis must be performed. (10) Electromagnetic compatibility and electrical, thermal, and mechanical safety testing must be performed. (11) Performance data must demonstrate the sterility of all patient-contacting device components. (12) Performance data must support the shelf life of the device components provided sterile by demonstrating continued sterility and package integrity over the labeled shelf life. (13) Performance data must validate the reprocessing instructions for the reusable components of the device. (14) Performance data must demonstrate that all patient-contacting components of the device are biocompatible. (15) Performance data must demonstrate that all patient-contacting components of the device are non-pyrogenic. (16) The device manufacturer must submit a report to the FDA annually on the anniversary of initial marketing authorization for the device, until such time as FDA may terminate such reporting, which comprises the following information: (i) Cumulative summary, by year, of complaints and adverse events since date of initial marketing authorization; and (ii) Identification and rationale for changes made to the device, labeling, or device specific use training program, which did not require submission of a premarket notification during the reporting period.

Predicate Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K123047 pg 1 of 4 ## 510(k) Summary | Submission Date: | | |------------------|--| |------------------|--| 26 September 2012 Submitter: Bracco Diagnostics, Inc. 107 College Road Princeton, NJ 08540 USA **Submitter and Official Contact:** Bracco Diagnostics Inc. 532 Broadhollow Road, Suite 126 Melville, NY 11747 Ms. Tracey Alexander Director Regulatory Affairs Phone: +1 (609) 524-2865 Fax: +1 (631) 847-3904 Email: tracey.alexander@diag.bracco.com Trade Name: LINE TUBING SET Common Name: Tubing Set Classification Name: Endoscope and accessories Classification 21 CFR §876.1500 Regulation: Product Code: FCX, FDS Substantially Equivalent Devices: BDI Model Predicate 510(k) Number K954451 Bracco Diagnostics, Inc. CO2 ENDOSCOPIC INSUFFLATOR IN . K053008 Bracco Diagnostics, Inc. CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET Predicate Manufacturer and Model AUG 0 6 2013 E-Z-EM, Inc. (now BDI) CO2 Efficient Endoscopic Insufflator Olympus America, Inc. EVIS 140 System (MH-970 Water Container Accessory) Page I of 4 {1}------------------------------------------------ ## K123047 pg 2 of 4 | Device Description: | The Bracco Diagnostics Inc. (BDI) CO2 ENDOSCOPIC<br>INSUFFLATOR IN LINE TUBING SET (ILTS) is intended for use<br>with BDI CO2 Endoscopic Insufflators and OEM endoscope systems, in<br>this specific case the Olympus® 140, 160, 180, and 190 series<br>endoscopes. | | | |--------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | The ILTS is supplied sterilized using Gamma radiation to a Sterility<br>Assurance Level (SAL) of 10-6. | | | | | The ILTS is individually packaged At the time of this submission,<br>accelerated aging tests confirmed a one (1) year shelf life. | | | | Intended Use: | The CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET is<br>intended to connect a CO2 source (insufflator), and a sterile water<br>source (water bottle), to an endoscope to supply CO2 during<br>gastrointestinal endoscopic procedures. | | | | Technology<br>Comparison: | The ILTS employs the same technological characteristics as the<br>predicate devices. | | | | Characteristic<br>Comparisons: | E-Z-EM, Inc.<br>(Bracco Diagnostics, Inc.)<br>CO2 ENDOSCOPIC<br>INSUFFLATOR Tubing Set<br>(K053008) | Olympus MH-970<br>Water Container<br>(Accessory within the<br>Olympus EVIS 140 Video<br>Endoscopy System)<br>(K954451) | Bracco Diagnostics, Inc.<br>CO2 ENDOSCOPIC<br>INSUFFLATOR<br>IN LINE TUBING SET | | Intended Use | The CO2 ENDOSCOPIC<br>INSUFFLATOR IN LINE<br>TUBING SET is intended<br>to be used with a CO2<br>source and insufflator,<br>along with a sterile water<br>source, to supply CO2 and<br>sterile water to an<br>endoscope during<br>gastrointestinal<br>endoscopic procedures. | The Olympus MH-970<br>Water Container is<br>intended to be used with a<br>CO2 source and<br>insufflator, along with a<br>sterile water source, to<br>supply CO2 and sterile<br>water to an endoscope<br>during endoscopic<br>procedures. | The CO2<br>ENDOSCOPIC<br>INSUFFLATOR IN<br>LINE TUBING SET<br>is intended to connect<br>a CO2 source<br>(insufflator), and a<br>sterile water source<br>(water bottle), to an<br>endoscope to supply<br>CO2 during<br>gastrointestinal<br>endoscopic<br>procedures. | | Compatibility | Connects to OEM<br>endoscope systems that<br>are equipped with an<br>external CO2 luer<br>connector. | Connects to Olympus®<br>140, series endoscopes. | Same for both predicates | | Sterility Method | Non-sterile. | Glutaraldehyde;<br>Autoclavable<br>(Provided non-sterile) | Radiation<br>(Provided sterile) | | Sterility Assurance Level | Not applicable | Unknown | 10-6 | | Disposable or Reusable | Disposable | Reusable | Disposable | | Packaging | Poly bag | Unknown | 10" x 14" Tyvek ®,<br>peelable pouch or similar | | Shelf-Life | Six (6) years | Unknown | One (1) year initially | {2}------------------------------------------------ #### Performance Testing: Sterilization Shelf-Life The ILTS is gamma radiation sterilized and was validated to a sterility assurance level of 106 in accordance with the following standards: - · ISO 11137-1: 2006, Sterilization of health care products -Requirements for validation and routine control – Radiation sterilization; and - ISO 11137-2:2006 (currently under revision), Sterilization of health . care products -- Radiation -- Part 2: Establishing the sterilization dose. Verification results indicate that the ILTS complies with the standards. The ILTS is sterilized and its packaging was validated in accordance with the following standards: - ISO 11607-1: 2006 Packaging for terminally sterilized medical . devices - Part 1 : requirements for materials, sterile barrier systems and packaging systems; and - . ISO 11607-2: 2006 Packaging for terminally sterilized medical devices - Part 2: Validation requirements for forming, sealing and assembly processes. Verification results indicate that the ILTS complies with the standards. Biocompatibility ILTS patient contact materials were verified in accordance with the following standard: - . ISO 10993-1: 2009, Biological evaluation of medical devices - Part I : Evaluation and testing within a risk management process. Verification results indicated that the ILTS patient contact materials comply with the standard. {3}------------------------------------------------ ### K123047 pg 4 of 4 The ILTS was tested for performance in accordance with its Performance Testing predetermined specifications. Testing included: – Bench - . Device compatibility; - Usability; . - Environmental; . - Delivery flow rate; . - . Delivery pressure; - . Leakage; - . Mechanical integrity; - Shipping and transportation; and . - . Labeling. Test results indicate that the ILTS complies with its predetermined specification. Verification and validation activities were conducted to establish the Conclusion performance and safety characteristics of the ILTS. The results of these activities demonstrate that the ILTS is safe and effective when used in accordance with its intended use and labeling. > Therefore, the ILTS is considered substantially equivalent to the predicate devices. {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the logo for the Department of Health and Human Services (HHS). The logo features a stylized eagle with three stripes representing the three branches of government. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Dacument Control Center - WO66-G609 Silver Spring, MD 20993-0002 August 6, 2013 Bracco Diagnostics, Inc. % Tracey Alexander Director Regulatory Affairs 532 Broadhollow Road, Suite 126 Melville, NY 11747 Re: K123047 Trade/Device Name: Bracco Diagnostics, Inc. CO2ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: FCX, FDS Dated: July 12, 2013 Received: July 26, 2013 Dear Tracey Alexander. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or 10 devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warrantics. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {5}------------------------------------------------ #### Page 2 - Tracey Alexander Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, # Herbert P. Lerner -S for Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ Indications for Use 510(k) Number (if known): K 123047 Device Name: Bracco Diagnostics, Inc. CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET Indications for Use: The CO2 ENDOSCOPIC INSUFFLATOR IN LINE TUBING SET is intended to connect a CO2 source (insufflator), and a sterile water source (water bottle), to an endoscope to supply CO2 during gastrointestinal endoscopic procedures. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) # Herbert P. Lerner -S (Division Sign-Off) Division of Reproductive, Gastro-Renal, and Urological Devices K123047 510(k) Number _ Page 1 of 1
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...